AI in Oncology Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033
The AI in Oncology Market size was valued at US$ 3.62 Billion in 2025 and is projected to reach US$ 29.08 Billion by 2033, growing at a CAGR of 29.75% during 2026–2033. Rising cancer incidence, expanding medical imaging datasets, precision medicine adoption, and AI-enabled clinical decision-making are accelerating industry expansion while creating opportunities in biomarker discovery and personalized therapies.
Report Coverage
- Component: Hardware/Devices, Software & Services
- Deployment: Cloud-based, On-Premise & Hybrid
US$ 3.62 Bn
Market size in 2025
US$ 29.08 Bn
Market Size by 2033
29.75%
CAGR, 2026 - 2033
2026-2033
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. AI in Oncology Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. AI in Oncology Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. AI in Oncology Market Global Analysis
6.2 AI in Oncology Market Revenue 2022-2033 (US$ Billion)
6.3 AI in Oncology Market Forecast Analysis
7. AI in Oncology Market Analysis – by Component
7.1 Hardware/Devices
- 7.1.1 Overview
- 7.1.2 Hardware/Devices: AI in Oncology Market – Revenue and Forecast, 2022-2033 (US$ Billion)
7.2 Software & Services
- 7.2.1 Overview
- 7.2.2 Software & Services: AI in Oncology Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8. AI in Oncology Market Analysis – by Deployment
8.1 Cloud-based
- 8.1.1 Overview
- 8.1.2 Cloud-based: AI in Oncology Market – Revenue and Forecast, 2022-2033 (US$ Billion)
8.2 On-Premise & Hybrid
- 8.2.1 Overview
- 8.2.2 On-Premise & Hybrid: AI in Oncology Market – Revenue and Forecast, 2022-2033 (US$ Billion)
9. AI in Oncology Market – Geographic Analysis
9.1 Overview
9.2 North America- 9.2.1 AI in Oncology Market Breakdown, by Key Country, 2026 and 2033 (%)
- 9.2.1.1 AI in Oncology Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.2.1.1.1 US: AI in Oncology Market Breakdown, by Component
- 9.2.1.1.2 US: AI in Oncology Market Breakdown, by Deployment
- 9.2.1.2 Canada: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.2.1.2.1 Canada: AI in Oncology Market Breakdown, by Component
- 9.2.1.2.2 Canada: AI in Oncology Market Breakdown, by Deployment
- 9.2.1.3 Mexico : AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.2.1.3.1 Mexico : AI in Oncology Market Breakdown, by Component
- 9.2.1.3.2 Mexico : AI in Oncology Market Breakdown, by Deployment
- 9.3.1 AI in Oncology Market Breakdown, by Key Country, 2026 and 2033 (%)
- 9.3.1.1 AI in Oncology Market – Revenue and Forecast Analysis – by Country
- 9.3.1.1 Germany: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.1.1 Germany: AI in Oncology Market Breakdown, by Component
- 9.3.1.1.2 Germany: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.2 Italy: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.2.1 Italy: AI in Oncology Market Breakdown, by Component
- 9.3.1.2.2 Italy: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.3 France: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.3.1 France: AI in Oncology Market Breakdown, by Component
- 9.3.1.3.2 France: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.4 U.K.: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.4.1 U.K.: AI in Oncology Market Breakdown, by Component
- 9.3.1.4.2 U.K.: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.5 Spain: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.5.1 Spain: AI in Oncology Market Breakdown, by Component
- 9.3.1.5.2 Spain: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.6 Belgium: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.6.1 Belgium: AI in Oncology Market Breakdown, by Component
- 9.3.1.6.2 Belgium: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.7 Netherlands: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.7.1 Netherlands: AI in Oncology Market Breakdown, by Component
- 9.3.1.7.2 Netherlands: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.8 Luxembourg: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.8.1 Luxembourg: AI in Oncology Market Breakdown, by Component
- 9.3.1.8.2 Luxembourg: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.9 Norway: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.9.1 Norway: AI in Oncology Market Breakdown, by Component
- 9.3.1.9.2 Norway: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.10 Finland: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.10.1 Finland: AI in Oncology Market Breakdown, by Component
- 9.3.1.10.2 Finland: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.11 Denmark: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.11.1 Denmark: AI in Oncology Market Breakdown, by Component
- 9.3.1.11.2 Denmark: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.12 Sweden: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.12.1 Sweden: AI in Oncology Market Breakdown, by Component
- 9.3.1.12.2 Sweden: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.13 Switzerland: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.13.1 Switzerland: AI in Oncology Market Breakdown, by Component
- 9.3.1.13.2 Switzerland: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.14 Austria: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.14.1 Austria: AI in Oncology Market Breakdown, by Component
- 9.3.1.14.2 Austria: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.15 Greece: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.15.1 Greece: AI in Oncology Market Breakdown, by Component
- 9.3.1.15.2 Greece: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.16 Portugal: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.16.1 Portugal: AI in Oncology Market Breakdown, by Component
- 9.3.1.16.2 Portugal: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.17 Russia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.17.1 Russia: AI in Oncology Market Breakdown, by Component
- 9.3.1.17.2 Russia: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.18 Poland: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.18.1 Poland: AI in Oncology Market Breakdown, by Component
- 9.3.1.18.2 Poland: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.19 Romania: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.19.1 Romania: AI in Oncology Market Breakdown, by Component
- 9.3.1.19.2 Romania: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.20 Czech Republic: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.20.1 Czech Republic: AI in Oncology Market Breakdown, by Component
- 9.3.1.20.2 Czech Republic: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.21 Ukraine: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.21.1 Ukraine: AI in Oncology Market Breakdown, by Component
- 9.3.1.21.2 Ukraine: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.22 Slovakia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.22.1 Slovakia: AI in Oncology Market Breakdown, by Component
- 9.3.1.22.2 Slovakia: AI in Oncology Market Breakdown, by Deployment
- 9.3.1.23 Bulgaria : AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.3.1.23.1 Bulgaria : AI in Oncology Market Breakdown, by Component
- 9.3.1.23.2 Bulgaria : AI in Oncology Market Breakdown, by Deployment
- 9.4.1 AI in Oncology Market Breakdown, by Key Country, 2026 and 2033 (%)
- 9.4.1.1 AI in Oncology Market – Revenue and Forecast Analysis – by Country
- 9.4.1.1 China: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.1.1 China: AI in Oncology Market Breakdown, by Component
- 9.4.1.1.2 China: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.2 Japan: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.2.1 Japan: AI in Oncology Market Breakdown, by Component
- 9.4.1.2.2 Japan: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.3 South Korea: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.3.1 South Korea: AI in Oncology Market Breakdown, by Component
- 9.4.1.3.2 South Korea: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.4 India: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.4.1 India: AI in Oncology Market Breakdown, by Component
- 9.4.1.4.2 India: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.5 Australia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.5.1 Australia: AI in Oncology Market Breakdown, by Component
- 9.4.1.5.2 Australia: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.6 New Zealand: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.6.1 New Zealand: AI in Oncology Market Breakdown, by Component
- 9.4.1.6.2 New Zealand: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.7 Indonesia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.7.1 Indonesia: AI in Oncology Market Breakdown, by Component
- 9.4.1.7.2 Indonesia: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.8 Malaysia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.8.1 Malaysia: AI in Oncology Market Breakdown, by Component
- 9.4.1.8.2 Malaysia: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.9 Philippines: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.9.1 Philippines: AI in Oncology Market Breakdown, by Component
- 9.4.1.9.2 Philippines: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.10 Singapore: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.10.1 Singapore: AI in Oncology Market Breakdown, by Component
- 9.4.1.10.2 Singapore: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.11 Thailand: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.11.1 Thailand: AI in Oncology Market Breakdown, by Component
- 9.4.1.11.2 Thailand: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.12 Vietnam: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.12.1 Vietnam: AI in Oncology Market Breakdown, by Component
- 9.4.1.12.2 Vietnam: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.13 Taiwan: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.13.1 Taiwan: AI in Oncology Market Breakdown, by Component
- 9.4.1.13.2 Taiwan: AI in Oncology Market Breakdown, by Deployment
- 9.4.1.14 Bangladesh : AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.4.1.14.1 Bangladesh : AI in Oncology Market Breakdown, by Component
- 9.4.1.14.2 Bangladesh : AI in Oncology Market Breakdown, by Deployment
- 9.5.1 AI in Oncology Market Breakdown, by Key Country, 2026 and 2033 (%)
- 9.5.1.1 AI in Oncology Market – Revenue and Forecast Analysis – by Country
- 9.5.1.1 Brazil: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.5.1.1.1 Brazil: AI in Oncology Market Breakdown, by Component
- 9.5.1.1.2 Brazil: AI in Oncology Market Breakdown, by Deployment
- 9.5.1.2 Argentina: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.5.1.2.1 Argentina: AI in Oncology Market Breakdown, by Component
- 9.5.1.2.2 Argentina: AI in Oncology Market Breakdown, by Deployment
- 9.5.1.3 Chile: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.5.1.3.1 Chile: AI in Oncology Market Breakdown, by Component
- 9.5.1.3.2 Chile: AI in Oncology Market Breakdown, by Deployment
- 9.5.1.4 Colombia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.5.1.4.1 Colombia: AI in Oncology Market Breakdown, by Component
- 9.5.1.4.2 Colombia: AI in Oncology Market Breakdown, by Deployment
- 9.5.1.5 Peru : AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.5.1.5.1 Peru : AI in Oncology Market Breakdown, by Component
- 9.5.1.5.2 Peru : AI in Oncology Market Breakdown, by Deployment
- 9.6.1 AI in Oncology Market Breakdown, by Key Country, 2026 and 2033 (%)
- 9.6.1.1 AI in Oncology Market – Revenue and Forecast Analysis – by Country
- 9.6.1.1 Saudi Arabia: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.1.1 Saudi Arabia: AI in Oncology Market Breakdown, by Component
- 9.6.1.1.2 Saudi Arabia: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.2 United Arab Emirates: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.2.1 United Arab Emirates: AI in Oncology Market Breakdown, by Component
- 9.6.1.2.2 United Arab Emirates: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.3 Kuwait: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.3.1 Kuwait: AI in Oncology Market Breakdown, by Component
- 9.6.1.3.2 Kuwait: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.4 Bahrain: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.4.1 Bahrain: AI in Oncology Market Breakdown, by Component
- 9.6.1.4.2 Bahrain: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.5 Qatar: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.5.1 Qatar: AI in Oncology Market Breakdown, by Component
- 9.6.1.5.2 Qatar: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.6 Oman: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.6.1 Oman: AI in Oncology Market Breakdown, by Component
- 9.6.1.6.2 Oman: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.7 Turkiye: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.7.1 Turkiye: AI in Oncology Market Breakdown, by Component
- 9.6.1.7.2 Turkiye: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.8 South Africa: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.8.1 South Africa: AI in Oncology Market Breakdown, by Component
- 9.6.1.8.2 South Africa: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.9 Egypt: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.9.1 Egypt: AI in Oncology Market Breakdown, by Component
- 9.6.1.9.2 Egypt: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.10 Nigeria: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.10.1 Nigeria: AI in Oncology Market Breakdown, by Component
- 9.6.1.10.2 Nigeria: AI in Oncology Market Breakdown, by Deployment
- 9.6.1.11 Algeria: AI in Oncology Market – Revenue and Forecast to 2033 (US$ Billion)
- 9.6.1.11.1 Algeria: AI in Oncology Market Breakdown, by Component
- 9.6.1.11.2 Algeria: AI in Oncology Market Breakdown, by Deployment
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 IBM Corporation
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 NVIDIA Corporation
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Siemens Healthineers AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GE HealthCare Technologies Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Tempus AI, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 PathAI, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ConcertAI, Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Microsoft Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Digital Diagnostics Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Median Technologies SA
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.